CC
ISEE

Caxton Corporation’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Caxton Corporation’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-203,414
Closed -$1.28M – 61
2021
Q2 		$1.28M Buy
203,414
+56,048
+38% +$362K 0.88% 14
2021
Q1 		$911K Buy
147,366
+12,385
+9% +$75.2K 0.59% 16
2020
Q4 		$933K Sell
134,981
-57,757
-30% -$370K 0.58% 18
2020
Q3 		$1.09M Buy
192,738
+67,967
+54% +$324K 1.02% 11
2020
Q2 		$636K Buy
+124,771
New +$520K 0.67% 13

Other funds holding ISEE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caxton Corporation's ISEE Position: Q3 2021 in Review

Caxton Corporation sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2021, closing a stake of 203,414 shares — an estimated $1.28M sold.

Caxton Corporation first reported a position in ISEE in Q2 2020 and held it in 5 quarters. The position peaked at $1.28M in Q2 2021. 149 funds tracked by Wall St. Rank hold ISEE as of Q3 2021.

  • Caxton Corporation reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Caxton Corporation sold 203,414 IVERIC bio, Inc. Common Stock shares in Q3 2021, an estimated $1.28M.
  • Caxton Corporation first reported a position in IVERIC bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • Caxton Corporation's IVERIC bio, Inc. Common Stock position peaked at $1.28M in Q2 2021.
  • 149 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2021.

Based on Caxton Corporation's 13F filing for Q3 2021, filed 15 Nov 2021.